Risk Factors and Prevalence for Latent Tuberculosis Infection among Health Care Workers in Al-Quwayiyah General Hospital Riyadh, KSA

Main Article Content

Enas Sh. Khater
Khalid H. M. Abdo


Background: All health care facilities should intensify TB screening and encourage treatment of latent tuberculosis infection (LTBI) among Healthcare workers (HCWs) to prevent progression to tuberculosis (TB) disease.

Aim: This study was conducted to determine the prevalence and associated risk factors of LTBI among HCWs in Al Quwayiyah General hospital as well as to compare the performance of QuantiFERON-TB Gold Plus (QFT-Plus) to TST in identifying LTBI.

Methods: A cross sectional study and prospective cohort study was performed from January to July 2019 in Al Quwayiyah General hospital involving a total of 718 HCWs. questionnaire with socio-demographic data and work history was filled, and both tests were done TST and QFT test for each Healthcare worker.

Results: The study showed that The prevalence of latent tuberculosis diagnosed was 9.05% and 9.19% using QFT-Plus and TST respectively. Only 26 (3.62%) subjects were positive for both tests whereas 131 (18.25%) were positive by either test. Comparing the results of the QFT-Plus with those of the TST, both tests had a significant total agreement of 88.8. Negative concordance comprised 85.37% of the results, and positive concordance comprised 3.62%. However, positive TST but negative QFT-Plus comprised 5.57% of the results, and negative TST but positive QFT-Plus comprised 5.43%. The association between risk factors and QFT-Plus test results in the studied groups showed that the smoking, health status, immunosuppresion, housing, occupation, contact T.B. at work place, past history of TB and diabetes mellitus appear as significant risk factors. The association between the studied risk factors and TST in the studied groups showed sig­nificant difference noted for smoking, BCG vaccination, immunosuppresion, housing, occupation, contact T.B. at work place, past history of TB and diabetes mellitus.

Conclusion: The prevalence of latent tuberculosis diagnosed was 9.05% and 9.19% using QFT-Plus and TST respectively. Testing of HCWs at hire and periodically can help in the detection of LTBI Large scale study is recommended to confirm such findings in Saudi Arabia, also the use of Quantiferon for detection of LTBI beside using TST is recommended as it reduce the false positive reports by TST and is not affected by prior BCG status.

Latent tuberculosis, tuberculin skin, healthcare workers, QuantiFERON-TB gold plus.

Article Details

How to Cite
Khater, E. S., & Abdo, K. H. M. (2020). Risk Factors and Prevalence for Latent Tuberculosis Infection among Health Care Workers in Al-Quwayiyah General Hospital Riyadh, KSA. Microbiology Research Journal International, 29(6), 1-11. https://doi.org/10.9734/mrji/2019/v29i630183
Original Research Article


World Health Organization. What Is DOTS?: A guide to understanding the WHO-recommended TB control strategy known as DOTS; World Health Organization: Geneva, Switzerland, 1999.

Kiazyk S, Ball T. Tuberculosis (TB): Latent tuberculosis infection: An overview. Can. Commun. Dis. Rep. 2017;43- 62.

Sidhu A, Verma G, Humar A, Kumar D. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Transplantation. 2014;98:671–675.

Corbett EL, Muzangwa J, Chaka K, Dauya E, Cheung YB, Munyati SS, Reid A, Hakim J, Chandiwana S, Mason PR. Nursing and community rates of Mycobacterium tuberculosis infection among students in Harare, Zimbabwe. Clin. Infect. Dis. 2007; 44:317–323.

Abdalhamid B, Hinrichs S, Garrett J, O’Neill J, Hansen-Cain J, Armbrust A,2 and Iwen1P: Utilization of the QuantiFERON-TB gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis. Journal Of Clinical Microbiology. 2010;2955–2956.

Taggart EW, Hill HR, Ruegner RG, Martins TB, Litwin CM. Evaluation of an in vitro assay for gamma interferon production in response to Mycobacterium tuberculosis infections. Clin Diagn Lab Immunol. 2004; 11:1089–93.

Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000; 356:1099–104.

Pai M, Riley LW, Colford JM, Jr Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis. 2004;4:761–76.

Petruccioli E, Chiacchio T, Pepponi I, et al. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus. J Infect. 2016;73:588–597.

Qiagen. QuantiFERON®-TB gold plus (QFT®-Plus) ELISA Package Insert.

Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H. WHO’s new end TB strategy. Lancet. 2015;385:1799–1801.

Andersen P, et al. Specific immune-based diagnosis of tuberculosis. Lancet. 2000; 356:1099.

Turner J, et al. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology. 1996;87:339.

Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low-and middle-income countries: A systematic review. PLoS Med. 2006;3: 494-499.

Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, et al. Prevalence of tuberculosis infection in the United States population: The national health and nutrition examination survey, 1999-2000. Am J Respir Crit Care Med. 2008;177(3):348-55.

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tu¬berculosis: A systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152.

Costa JT, Silva R, Sá R, Cardoso MJ, Ferreira J, Ribeiro C, et al. Tuber¬culosis – risk of continued transmission in health-care workers. Rev Port Pneumol. 2010; 16(1):5-21.

Abbas MA, AlHamdan NA, Fiala LA, AlEnezy AK, AlQahtani MS. Prevalence of latent TB among health care workers in four major tertiary care hospitals in Riyadh, Saudi Arabia. J Egypt Public Health Assoc 2010;85:61-71.

Nienhaus A, Schablon A, Loddenkemper R, Hauer B, Wolf N, Diel R. Prevalence of latent tuberculosis infection in healthcare workers in geriatric care. Pneumologie 2007;61:613-616.

Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle-income countries: A systematic review. PLoS Med 2006;3: 494.

Schablon A, Harling M, Diel R, Nienhaus A. Risk of latent TB infection in individuals employed in the healthcare sector in Germany: A multicentre prevalence study. BMC Infect Dis. 2010;10:107

Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, et al. Comparison of QFT-Plus test and tuberculin skin test for identification of latent mycobacterium tuberculosis Infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol. 2009;30: 215–221.

Caglayan V, Ak O, Dabak G, Damadoglu E, Ketenci B, Ozdemir M, et al. Comparison of tuberculin skin testing and QuantiFERON-TB gold-in tube test in health care workers. Tuberk Toraks. 2011; 59:43–7.

Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, et al. Mycobacterium tuberculosis infection in health care workers in rural India: Comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA. 2005;293:2746–55.

Khoury NZ, Binnicker MJ, Wengenack NL, Aksamit TR, Buchta WG, Molella RG. Preemployment screening for tuberculosis in a large health care setting: Comparison of the tuberculin skin test and a whole-blood interferon-gamma release assay. J Occup Environ Med. 2011;53:290–3.

Zhao X, Mazlagic D, Flynn EA, Hernandez H, Abbott CL. Is the QuantiFERON-TB blood assay a good replacement for the tuberculin skin test in tuberculosis screening. A pilot study at Berkshire Medical Center? Am J Clin Pathol. 2009; 132:678–86.

Jong Lee K, Ae Kang Y, Mi Kim Y, Cho SN, Wook Moon J, Suk Park M, et al. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay. Scand J Infect Dis. 2010;42:672–8.

Talebi-Taher M, Javad-Moosavi SA, Entezari AH, Shekarabi M, Parhizkar B. Comparing the performance of QuantiFERON-TB gold and mantoux test in detecting latent tuberculosis infection among Iranian health care workers. Int J Occup Med Environ Health. 2011;24:359–66.

Franken WP, Timmermans JF, Prins C, Slootman EJ, Dreverman J, Bruins H, et al. Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel. Clin Vaccine Immunol. 2007; 14:477–80.

El-Helaly M, Khan W, El-Saed A, Balkhy HH. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia. J Infect Public Health. 2014;7:481–8.

Hassan H, Shorman M, Housawi A, Elsammak M. Detecting latent tuberculosis infection prior to kidney transplantation in a tertiary hospital in Saudi Arabia: Comparison of the T-SPOT. TB test and tuberculin test. Br Microbiol Res J. 2013; 3:116–27.

Belo C, S. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Nampula Central Hospital, Mozambique BMC Infect Dis. 2017;17: 408.

Tan LH, Kamarulzaman A, Liam CK, Lee TC. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur. Malaysia Infect Control Hosp Epidemiol. 2002;23(10):584–590.

CDC. Protect Your Family and Friends from TB: The TB Contact Investigation.
Available:http://www.CDC.gov/tb/publications/ pamphlets/ TB_ contact_ investigation. pdf

TB Control Programs.

Dodig S, Zrinski Topić R, Živčić J. Latent tuberculosis infection in a subject with diabetes mellitus – a case report. Biochem Med (Zagreb). 2008;18(3):368-73.

Haley CA, Cain KP, Yu C, Garman KF, Wells CD, Laserson KF. Risk-based screening for latent tuberculosis infection. South Med J. 2008;101(2):142-9.

Yanai H, Limpakarnjanarat K, Uthaivoravit W, Mastro TD, Mori T, Tappero JW. Risk of Mycobacterium tuberculosis infection and disease among health care workers, Chiang Rai, Thailand. Int J Tuberc Lung Dis. 2003;7(1):36-45.

Dheda K, Chang JS, Kim LU, Huggett JF, Johnson MA, Zumla A, et al. Interferon gamma assays for tuberculosis. Lancet Infect Dis. 2005;5(6):324-5.